GenEmbryomics

Don't miss this month's Progenesis Academy webinar, 'Precision Parenting: Powering Pre-Implantation Diagnosis with Whole Genome Sequencing', happening on September 18th at 3pm PST. Register now through the link below to hear insights from our expert speakers, Pamela Callum and Nick Murphy! https://lnkd.in/eMwKmPjr #ivf #ivfjourney?#infertility #ivfsuccess #ivfwarrior #ttccommunity #ivfcommunity #ttc #fertility #infertilityjourney?#ivftransfer #ivftreatment #ivfstory #embryo #embryology #ttcsupport?

Congratulations to the #PGDIS organizing committee for successfully bringing together experts in the field of genetic testing at the 2024 conference in Malaysia. Our founder Nick Murphy was truly honored to be invited to present at this esteemed event and share our knowledge on preimplantation genetic testing with whole-genome sequencing (PGT-WGS) and our groundbreaking Panacea-GenomeScreen test.

I'm pleased to update with big news - GenEmbryomics and Progenesis are joining forces to transform reproductive medicine. Together we'll provide Panacea-GenomeScreen?, the IVF embryo preimplantation genetic test with whole-genome sequencing (PGT-WGS) that screens for both inherited and de novo mutations, variations both big and small. Our goal is to empower fertility patients with the most advanced technologies and give them the best chance at starting a family. I'm incredibly proud of our teams' shared commitment to innovation and improving outcomes for those on their fertility journey. #GenEmbryomics #Progenesis #GeneticTesting #PGTWGS #IVF #wholegenomesequencing #infertility https://lnkd.in/gcGzr6HB

On the latest episode of Build It. They'll Come. with Helen Dalley meet scientist-turned-entrepreneur Nick Murphy, founder of GenEmbryomics - a super smart dude on the frontier of reproductive medicine. Nick (pictured below) with his small, highly skilled team developed a world-first -- a pre-implantation genetic screening test for IVF embryos, capable of detecting several thousand severe or life-threatening genetic diseases. Thereby giving parents more information at the pre-implantation stage, to have far better outcomes. And it's one single, simple test. The genius is, this test involves whole genome sequencing of the pre-implantation embryo, and of the genetic parents. Nick Murphy's startup GenEmbryomics is commercialising their test, to be offered through existing IVF clinics, at as low a price as possible, and to as many couples going through IVF, as need it. Although university educated in Melbourne and now working from his Melbourne lab, Nick Murphy's test isn't yet commercially available in Australia. GenEmbryomics is in the process of securing patents for it in the massive IVF market in the United States, worth some US$9 billion, with plans to expand into Europe. They intend listing on New York's Nasdaq exchange by mid-2024, with the help of chair Paul Viney and Artesian (Alternative Investments) Venture Partners and Rohan Gray. What a wild and fascinating journey for this scientist and genetic testing specialist since he started GenEmbryomics, building it up from scratch in 2019. Listen now on your fave podcast platform. #genetics #IVF #preimplantationgenetictesting #science #startups #genomesequencing #venturecapital #nasdaq #genetictesting #finance #publicfloat #entrepreneurs #business

GenEmbryomics Founder Nick Murphy PhD and Broadcast Journalist Helen Dalley engage in a thought-provoking dialogue on genetic embryo testing in the latest episode of 'Build It. They'll Come'. Don't miss their insightful discussion, now streaming on Apple Podcasts, Spotify, and other major platforms. https://lnkd.in/g7-8jvUn #GenEmbryomics #MedicalGenetics #USListing #Innovation #Biotechnology #genomics #genetics #reproductivegenetics #genetichealth #BioTechAdvances #genomicresearch #genomicinnovation #DNASequencing #Bioinformatics #GenomicRevolution #biotech #innovationingenomics #GenomicBreakthrough #GenomeMapping #pgtwgs

Exciting News: GenEmbryomics gears up for a major milestone in our journey towards global expansion. We're thrilled to announce the appointment of Saadia Basharat, a distinguished industry expert based in San Diego, to our Board of Directors! Saadia's wealth of experience in healthcare, biotechnology, and strategic business development will be invaluable as we prepare for listing on a major US national exchange. "Saadia’s deep understanding of the pharmaceutical and biotech industries, combined with her expertise in program strategy and business development, will undoubtedly enhance our capabilities in navigating the complex landscape of medical genetics," says Nick Murphy, PhD, GenEmbryomics' Founder and CEO. Join us in welcoming Saadia aboard as we chart our course toward continued growth and innovation! Learn more about GenEmbryomics and our GenomeScreen testing at genembryomics.com. #GenEmbryomics #MedicalGenetics #CorporateGovernance #USListing #Innovation #Biotechnology #genomics #genetics #reproductivegenetics #genetichealth #BioTechAdvances #genomicresearch #genomicinnovation #DNASequencing #Bioinformatics #GenomicRevolution #biotech #innovationingenomics #GenomicBreakthrough #GenomeMapping #PGTWGS